GENFIT
Last · —$7.92+0.09 (+1.15%)live · yahoo · 0s ago
Market cap——
P/E · TTM307fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
| Revenue | €70.9M |
|---|---|
| Operating income | €3.3M |
| Net income | €1.5M |
| Free cash flow | €14.6M |
| Operating margin | 4.6% |
| Net margin | 2.1% |
| Return on equity | 2.2% |
| Period | 2024 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2026-04-03
- Operating Cf Burn
- Net Margin Sharply Negative
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -120.9%
Press & signals
- GlobeNewswire
GENFIT Reports First-Half 2026 Financial Results and Provides Corporate Update
- GlobeNewswire
GENFIT Advances Nangibotide in Phase 2 Clinical Investigation in ACLF
- GlobeNewswire
GENFIT to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags